6 melanoma helper peptide vaccine

From WikiMD's free health, diet & wellness encyclopedia
Jump to navigation Jump to search

A multi-epitope vaccine containing the following six class II MHC-restricted peptides: gp100, MelanA/MART-1, two tyrosinase peptides, and the cancer/testis antigens MAGE-A3 and MAGE-A1,2,3,6, with potential antineoplastic activity. Upon administration, melanoma helper peptides induce an antigen-specific, Th1-dominant, CD4+ T-cell response, potentially augmenting cytotoxic T-cell (CTL) responses and maintaining immunologic memory against tumor cells expressing melanoma-specific antigens. The 6MHP vaccine may also induce a CD8+ T-cell response through epitope spreading, potentially priming subsequent immune responses against tumor cells.

Learn more about 6 melanoma helper peptide vaccine

Latest research - 6 melanoma helper peptide vaccine

Clinical trials

External links

Medicine icon
Medicine icon

This WikiMD article 6 melanoma helper peptide vaccine is a stub. If you are familiar with the topic 6 melanoma helper peptide vaccine, you can help us. Paid editors welcome!


6 melanoma helper peptide vaccine is part of WikiMD's free ^articles!

^6 melanoma helper peptide vaccine (article) is provided for informational purposes only. No expressed or implied warranties as to the validity of content.
WikiMD is not a substitute for professional advice. By accessing and using WikiMD you agree to the terms of use.
Templates etc. when imported from Wikipedia, are licensed under CC BY-SA 3.0. See full disclaimers.
W8MD weight loss logo

Ad. Tired of being overweight?. W8MD's physician weight loss program can HELP. Tele medicine available